Eldecalcitol is an analog of calcitriol, the active form of vitamin D.[1]
Commonly used in Japan for the treatment of osteoporosis.[2]
Osteoporosis is a common bone disease among the older generation, with an estimated prevalence of over 200 million people.[2] This condition often results in bone fractures due to abnormally low bone mass density, and is a leading cause of disability, especially among developed countries with longer average life spans.
^Hatakeyama S, Yoshino M, Eto K, Takahashi K, Ishihara J, Ono Y, et al. (July 2010). "Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71]". The Journal of Steroid Biochemistry and Molecular Biology. 121 (1–2): 25–8. doi:10.1016/j.jsbmb.2010.03.041. PMID 20304058. S2CID 19630314.
^ abSanford M, McCormack PL (September 2011). "Eldecalcitol: a review of its use in the treatment of osteoporosis". Drugs. 71 (13): 1755–70. doi:10.2165/11206790-000000000-00000. PMID 21902297. S2CID 46981685.
Eldecalcitol is an analog of calcitriol, the active form of vitamin D. Commonly used in Japan for the treatment of osteoporosis. Osteoporosis is a common...
exact mass: 490.3658 u) may refer to: Balsaminapentaol Cycloastragenol Eldecalcitol, an analog of Vitamin D This set index page lists chemical structure...